enGene (NASDAQ:ENGN) Lowered to “Neutral” Rating by UBS Group
UBS Group lowered shares of enGene (NASDAQ:ENGN – Free Report) from a buy rating to a neutral rating in a report issued on Friday morning, Marketbeat Ratings reports. They currently have $7.00 target price on the stock, down from their prior target price of $34.00. Several other equities research analysts have also recently commented on […]
UBS Group lowered shares of enGene (NASDAQ:ENGN – Free Report) from a buy rating to a neutral rating in a report issued on Friday morning, Marketbeat Ratings reports. They currently have $7.00 target price on the stock, down from their prior target price of $34.00. Several other equities research analysts have also recently commented on […]
